To develop a new drug, the choice of your partner is crucial. Time saving, tight budgets, expertise, rigor: your requirements correspond to the challenges faced from NCE characterization to market release of your drugs.
Consultancy, clinical research, operational and strategic partnerships, our services have only one goal: succeed, with you, in the challenges of a new drug development: Our Strength? We support you during the overall process:
We have performed hundreds of studies for which we have tested hundreds of centrally active new drugs. This experience positions Forenap as a worldwide leader in the early development of psychoactive drugs. Quantified EEG (qEEG) and ERPs, driving simulator, body sway, our state of the art technical platform, close to the lab, is available for very early evaluation of the activity of a molecule on the CNS. Our scientific knowledge of CNS is unique : it enables us to conduct atypical, specific and complicated projects. Our asset? Recommendation and support, in synergy with your team.
The 120 Forenap employees and our 72 beds Clinical Pharmacology Unit (6000m²) specifically built to improve clinical trial performance, enable a great flexibility and solutions fitting with the highest pharmaceutical industry and health authorities standards. The development process of a new drug requires flexibility and reactivity. This is how we consider our relationship with you, because the success of your project is a common goal.
Chosing Forenap for its CNS expertise and high level technological
platform is the best strategy to optimize your drug development
They trust Forenap“ Neurim has collaborated with Forenap for over 10 years. We have always found Forenap business, clinical and research team to be highly effective in that they has a keen understanding of specific trial needs and with remarkable capabilities and capacity in generating quality data." " It has been a pleasure to work with Forenap, experienced professionals for various phase I clinical studies. Forenap is a customer focused CRO who demonstrates efficiency whilst not neglecting the quality of the studies." “ Forenap is an ideal partner for small pharma companies wanting to speed-up their entry in phase I. It is always a pleasure to work with Forenap experts in preclinical and pharmaceutical services.†|